Shed vs SnagRx: Coaching and Name-Brand vs Compounded Pricing
Quick verdict: Shed vs SnagRx boils down to coaching and medication choice versus predictable low pricing. Shed pairs name-brand and compounded GLP-1 options with continuous coaching and a 2-minute approval assessment, while SnagRx focuses on compounded semaglutide and tirzepatide with locked flat pricing as low as $69/month on a 12-month plan. Read on for a direct comparison of the most distinctive differences.
Explore Shed’s name-brand and compounded GLP-1s
Key differences at a glance: medication type, pricing model, and support
The most important distinctions for Shed vs SnagRx are: (1) medication variety and regulatory status, (2) pricing structure and commitments, and (3) clinical support and coaching. These three areas determine whether a patient prioritizes branded options and behavioral support or lowest locked-in compounded pricing.
1) Medication options and regulatory notes
Shed: Offers both FDA-approved name-brand GLP-1 medications and compounded alternatives. The source emphasizes that compounded medications are not FDA-approved and are prepared by a licensed pharmacy based on a provider’s prescription. Medication is prescribed only after a clinician review determines treatment is appropriate.
SnagRx: Offers compounded semaglutide and tirzepatide only; compounded medications are produced in regulated facilities but are not FDA-approved finished products. SnagRx names its US 503A partner pharmacies and states that OpenLoop Health clinicians decide prescription eligibility after intake.
2) Pricing structure and what you pay
Shed: Lists compounded semaglutide injections starting at $199/month and compounded tirzepatide starting at $299/month, and advertises 10% off your first month. Shed does not publish standard pricing for all plans; patients receive personalized quotes after intake and coaching is bundled into monthly cost rather than quoted separately.
SnagRx: Advertises compounded semaglutide from $69/month and tirzepatide from $119/month on the 12-month plan, with month-to-month equivalents of $99 and $149. The $69 and $119 rates require a 12-month commitment; SnagRx highlights a price-locked flat rate at every dose for the duration of treatment.
3) Clinical support, coaching, and timelines
Shed: Integrates continuous coaching into treatment rather than providing prescription-only service. Shed promotes a 2-minute approval assessment followed by clinician review and coaching that starts with the plan. This model is positioned for patients seeking behavioral support alongside medication.
SnagRx: Does not provide coaching or nutrition programming. SnagRx provides clinician review through OpenLoop Health, with intake that takes about five minutes and clinicians typically reviewing within five hours and always within 24 hours, plus next-day shipping for approved orders.
Comparison table: Shed vs SnagRx
| Criteria | Shed | SnagRx |
|---|---|---|
| Medication types | Name-brand and compounded GLP-1 options | Compounded semaglutide and tirzepatide only |
| Starting price | Compounded semaglutide starting at $199/month; tirzepatide starting at $299/month; 10% off first month | From $69/month semaglutide and $119/month tirzepatide on 12-month plan; month-to-month higher |
| Pricing model | Personalized quote after intake; coaching bundled | Flat locked pricing at every dose for life on annual plan; different month-to-month prices |
| Coaching and program support | Continuous integrated coaching included | No coaching or nutrition programming provided |
| Clinician review & shipping | 2-minute assessment then clinician review before prescription | About 5-minute intake; clinician review typically within 5 hours; next-day temperature-controlled shipping |
Other considerations and guarantees
Shed notes a weight-loss guarantee with terms in the Terms and Conditions and reiterates that compounded medications are not FDA-approved. SnagRx states it provides a full refund if a prescription is declined and offers a 6-month weight-loss guarantee (terms apply). SnagRx also highlights LegitScript certification and named pharmacy partners.
See SnagRx pricing and price-lock details
How these differences affect your choice
If you need flexibility to access FDA-approved branded GLP-1s or want continuous behavioral coaching bundled into care, Shed provides name-brand options plus compounded alternatives and integrated coaching, with a fast 2-minute assessment and a personalized quote after intake. If your priority is predictable, bottom-of-market compounded pricing and a flat rate that will not increase as you titrate, SnagRx advertises compounded semaglutide from $69/month and locks that price on the 12-month plan, with clinician review through OpenLoop Health and next-day shipping.
Start Shed’s 2-minute assessment
Final thoughts on Shed vs SnagRx
For quick clarity on the primary keyword: Shed vs SnagRx centers on coaching and medication choice versus low, locked-in compounded pricing. Both platforms require clinician review and state that compounded medications are not FDA-approved finished products; differences are clear and should guide selection based on priorities.
Compare Shed options and coaching
Choose one if…
Choose Shed if you want access to FDA-approved name-brand GLP-1s alongside compounded options, continuous integrated coaching, and a quick 2-minute approval assessment. Choose SnagRx if you want the lowest locked-in compounded pricing on a 12-month plan and predictable flat pricing throughout titration, with named 503A pharmacies and fast shipping.